Global Pharmaceutical CXO Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Pharmaceutical CXO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 CRO
  • 1.2.3 CMO
  • 1.2.4 CDMO
• 1.3 Market by Application
  • 1.3.1 Global Pharmaceutical CXO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Pharmaceutical Companies
  • 1.3.3 Biotechnology Companies
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmaceutical CXO Market Perspective (2018-2029)
• 2.2 Global Pharmaceutical CXO Growth Trends by Region
  • 2.2.1 Pharmaceutical CXO Market Size by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Pharmaceutical CXO Historic Market Size by Region (2018-2023)
  • 2.2.3 Pharmaceutical CXO Forecasted Market Size by Region (2024-2029)
• 2.3 Pharmaceutical CXO Market Dynamics
  • 2.3.1 Pharmaceutical CXO Industry Trends
  • 2.3.2 Pharmaceutical CXO Market Drivers
  • 2.3.3 Pharmaceutical CXO Market Challenges
  • 2.3.4 Pharmaceutical CXO Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Pharmaceutical CXO by Players
  • 3.1.1 Global Pharmaceutical CXO Revenue by Players (2018-2023)
  • 3.1.2 Global Pharmaceutical CXO Revenue Market Share by Players (2018-2023)
• 3.2 Global Pharmaceutical CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Pharmaceutical CXO, Ranking by Revenue, 2021 VS 2022 VS 2023
• 3.4 Global Pharmaceutical CXO Market Concentration Ratio
  • 3.4.1 Global Pharmaceutical CXO Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CXO Revenue in 2022
• 3.5 Global Key Players of Pharmaceutical CXO Head office and Area Served
• 3.6 Global Key Players of Pharmaceutical CXO, Product and Application
• 3.7 Global Key Players of Pharmaceutical CXO, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CXO Breakdown Data by Type

• 4.1 Global Pharmaceutical CXO Historic Market Size by Type (2018-2023)
• 4.2 Global Pharmaceutical CXO Forecasted Market Size by Type (2024-2029)

5 Pharmaceutical CXO Breakdown Data by Application

• 5.1 Global Pharmaceutical CXO Historic Market Size by Application (2018-2023)
• 5.2 Global Pharmaceutical CXO Forecasted Market Size by Application (2024-2029)

6 North America

• 6.1 North America Pharmaceutical CXO Market Size (2018-2029)
• 6.2 North America Pharmaceutical CXO Market Size by Type
  • 6.2.1 North America Pharmaceutical CXO Market Size by Type (2018-2023)
  • 6.2.2 North America Pharmaceutical CXO Market Size by Type (2024-2029)
  • 6.2.3 North America Pharmaceutical CXO Market Share by Type (2018-2029)
• 6.3 North America Pharmaceutical CXO Market Size by Application
  • 6.3.1 North America Pharmaceutical CXO Market Size by Application (2018-2023)
  • 6.3.2 North America Pharmaceutical CXO Market Size by Application (2024-2029)
  • 6.3.3 North America Pharmaceutical CXO Market Share by Application (2018-2029)
• 6.4 North America Pharmaceutical CXO Market Size by Country
  • 6.4.1 North America Pharmaceutical CXO Market Size by Country: 2018 VS 2022 VS 2029
  • 6.4.2 North America Pharmaceutical CXO Market Size by Country (2018-2023)
  • 6.4.3 North America Pharmaceutical CXO Market Size by Country (2024-2029)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Pharmaceutical CXO Market Size (2018-2029)
• 7.2 Europe Pharmaceutical CXO Market Size by Type
  • 7.2.1 Europe Pharmaceutical CXO Market Size by Type (2018-2023)
  • 7.2.2 Europe Pharmaceutical CXO Market Size by Type (2024-2029)
  • 7.2.3 Europe Pharmaceutical CXO Market Share by Type (2018-2029)
• 7.3 Europe Pharmaceutical CXO Market Size by Application
  • 7.3.1 Europe Pharmaceutical CXO Market Size by Application (2018-2023)
  • 7.3.2 Europe Pharmaceutical CXO Market Size by Application (2024-2029)
  • 7.3.3 Europe Pharmaceutical CXO Market Share by Application (2018-2029)
• 7.4 Europe Pharmaceutical CXO Market Size by Country
  • 7.4.1 Europe Pharmaceutical CXO Market Size by Country: 2018 VS 2022 VS 2029
  • 7.4.2 Europe Pharmaceutical CXO Market Size by Country (2018-2023)
  • 7.4.3 Europe Pharmaceutical CXO Market Size by Country (2024-2029)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Pharmaceutical CXO Market Size (2018-2029)
• 8.2 China Pharmaceutical CXO Market Size by Type
  • 8.2.1 China Pharmaceutical CXO Market Size by Type (2018-2023)
  • 8.2.2 China Pharmaceutical CXO Market Size by Type (2024-2029)
  • 8.2.3 China Pharmaceutical CXO Market Share by Type (2018-2029)
• 8.3 China Pharmaceutical CXO Market Size by Application
  • 8.3.1 China Pharmaceutical CXO Market Size by Application (2018-2023)
  • 8.3.2 China Pharmaceutical CXO Market Size by Application (2024-2029)
  • 8.3.3 China Pharmaceutical CXO Market Share by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Pharmaceutical CXO Market Size (2018-2029)
• 9.2 Asia Pharmaceutical CXO Market Size by Type
  • 9.2.1 Asia Pharmaceutical CXO Market Size by Type (2018-2023)
  • 9.2.2 Asia Pharmaceutical CXO Market Size by Type (2024-2029)
  • 9.2.3 Asia Pharmaceutical CXO Market Share by Type (2018-2029)
• 9.3 Asia Pharmaceutical CXO Market Size by Application
  • 9.3.1 Asia Pharmaceutical CXO Market Size by Application (2018-2023)
  • 9.3.2 Asia Pharmaceutical CXO Market Size by Application (2024-2029)
  • 9.3.3 Asia Pharmaceutical CXO Market Share by Application (2018-2029)
• 9.4 Asia Pharmaceutical CXO Market Size by Region
  • 9.4.1 Asia Pharmaceutical CXO Market Size by Region: 2018 VS 2022 VS 2029
  • 9.4.2 Asia Pharmaceutical CXO Market Size by Region (2018-2023)
  • 9.4.3 Asia Pharmaceutical CXO Market Size by Region (2024-2029)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size (2018-2029)
• 10.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2018-2023)
  • 10.2.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2024-2029)
  • 10.2.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Type (2018-2029)
• 10.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2018-2023)
  • 10.3.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2024-2029)
  • 10.3.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Application (2018-2029)
• 10.4 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country: 2018 VS 2022 VS 2029
  • 10.4.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2018-2023)
  • 10.4.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2024-2029)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 WuXi AppTec
  • 11.1.1 WuXi AppTec Company Details
  • 11.1.2 WuXi AppTec Business Overview
  • 11.1.3 WuXi AppTec Pharmaceutical CXO Introduction
  • 11.1.4 WuXi AppTec Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.1.5 WuXi AppTec Recent Developments
• 11.2 Tigermed
  • 11.2.1 Tigermed Company Details
  • 11.2.2 Tigermed Business Overview
  • 11.2.3 Tigermed Pharmaceutical CXO Introduction
  • 11.2.4 Tigermed Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.2.5 Tigermed Recent Developments
• 11.3 Charles River Laboratories
  • 11.3.1 Charles River Laboratories Company Details
  • 11.3.2 Charles River Laboratories Business Overview
  • 11.3.3 Charles River Laboratories Pharmaceutical CXO Introduction
  • 11.3.4 Charles River Laboratories Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.3.5 Charles River Laboratories Recent Developments
• 11.4 Pharmaron Inc
  • 11.4.1 Pharmaron Inc Company Details
  • 11.4.2 Pharmaron Inc Business Overview
  • 11.4.3 Pharmaron Inc Pharmaceutical CXO Introduction
  • 11.4.4 Pharmaron Inc Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.4.5 Pharmaron Inc Recent Developments
• 11.5 Labcorp Drug Development
  • 11.5.1 Labcorp Drug Development Company Details
  • 11.5.2 Labcorp Drug Development Business Overview
  • 11.5.3 Labcorp Drug Development Pharmaceutical CXO Introduction
  • 11.5.4 Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.5.5 Labcorp Drug Development Recent Developments
• 11.6 Boehringer Ingelheim
  • 11.6.1 Boehringer Ingelheim Company Details
  • 11.6.2 Boehringer Ingelheim Business Overview
  • 11.6.3 Boehringer Ingelheim Pharmaceutical CXO Introduction
  • 11.6.4 Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.6.5 Boehringer Ingelheim Recent Developments
• 11.7 GenScript
  • 11.7.1 GenScript Company Details
  • 11.7.2 GenScript Business Overview
  • 11.7.3 GenScript Pharmaceutical CXO Introduction
  • 11.7.4 GenScript Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.7.5 GenScript Recent Developments
• 11.8 MabPlex International
  • 11.8.1 MabPlex International Company Details
  • 11.8.2 MabPlex International Business Overview
  • 11.8.3 MabPlex International Pharmaceutical CXO Introduction
  • 11.8.4 MabPlex International Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.8.5 MabPlex International Recent Developments
• 11.9 Shanghai ChemPartner
  • 11.9.1 Shanghai ChemPartner Company Details
  • 11.9.2 Shanghai ChemPartner Business Overview
  • 11.9.3 Shanghai ChemPartner Pharmaceutical CXO Introduction
  • 11.9.4 Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.9.5 Shanghai ChemPartner Recent Developments
• 11.10 Wuxi Biologics
  • 11.10.1 Wuxi Biologics Company Details
  • 11.10.2 Wuxi Biologics Business Overview
  • 11.10.3 Wuxi Biologics Pharmaceutical CXO Introduction
  • 11.10.4 Wuxi Biologics Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.10.5 Wuxi Biologics Recent Developments
• 11.11 Pharmablock
  • 11.11.1 Pharmablock Company Details
  • 11.11.2 Pharmablock Business Overview
  • 11.11.3 Pharmablock Pharmaceutical CXO Introduction
  • 11.11.4 Pharmablock Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.11.5 Pharmablock Recent Developments
• 11.12 Jiuzhou Pharma
  • 11.12.1 Jiuzhou Pharma Company Details
  • 11.12.2 Jiuzhou Pharma Business Overview
  • 11.12.3 Jiuzhou Pharma Pharmaceutical CXO Introduction
  • 11.12.4 Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.12.5 Jiuzhou Pharma Recent Developments
• 11.13 Asym Chemical
  • 11.13.1 Asym Chemical Company Details
  • 11.13.2 Asym Chemical Business Overview
  • 11.13.3 Asym Chemical Pharmaceutical CXO Introduction
  • 11.13.4 Asym Chemical Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.13.5 Asym Chemical Recent Developments
• 11.14 IQVIA
  • 11.14.1 IQVIA Company Details
  • 11.14.2 IQVIA Business Overview
  • 11.14.3 IQVIA Pharmaceutical CXO Introduction
  • 11.14.4 IQVIA Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.14.5 IQVIA Recent Developments
• 11.15 Syneos Health
  • 11.15.1 Syneos Health Company Details
  • 11.15.2 Syneos Health Business Overview
  • 11.15.3 Syneos Health Pharmaceutical CXO Introduction
  • 11.15.4 Syneos Health Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.15.5 Syneos Health Recent Developments
• 11.16 Parexel
  • 11.16.1 Parexel Company Details
  • 11.16.2 Parexel Business Overview
  • 11.16.3 Parexel Pharmaceutical CXO Introduction
  • 11.16.4 Parexel Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.16.5 Parexel Recent Developments
• 11.17 AGC Biologics
  • 11.17.1 AGC Biologics Company Details
  • 11.17.2 AGC Biologics Business Overview
  • 11.17.3 AGC Biologics Pharmaceutical CXO Introduction
  • 11.17.4 AGC Biologics Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.17.5 AGC Biologics Recent Developments
• 11.18 FUJIFILM Diosynth Biotechnologies
  • 11.18.1 FUJIFILM Diosynth Biotechnologies Company Details
  • 11.18.2 FUJIFILM Diosynth Biotechnologies Business Overview
  • 11.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Introduction
  • 11.18.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.18.5 FUJIFILM Diosynth Biotechnologies Recent Developments
• 11.19 Patheon
  • 11.19.1 Patheon Company Details
  • 11.19.2 Patheon Business Overview
  • 11.19.3 Patheon Pharmaceutical CXO Introduction
  • 11.19.4 Patheon Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.19.5 Patheon Recent Developments
• 11.20 Catalent
  • 11.20.1 Catalent Company Details
  • 11.20.2 Catalent Business Overview
  • 11.20.3 Catalent Pharmaceutical CXO Introduction
  • 11.20.4 Catalent Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.20.5 Catalent Recent Developments
• 11.21 Lonza Group AG
  • 11.21.1 Lonza Group AG Company Details
  • 11.21.2 Lonza Group AG Business Overview
  • 11.21.3 Lonza Group AG Pharmaceutical CXO Introduction
  • 11.21.4 Lonza Group AG Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.21.5 Lonza Group AG Recent Developments
• 11.22 Avid Bioservices
  • 11.22.1 Avid Bioservices Company Details
  • 11.22.2 Avid Bioservices Business Overview
  • 11.22.3 Avid Bioservices Pharmaceutical CXO Introduction
  • 11.22.4 Avid Bioservices Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.22.5 Avid Bioservices Recent Developments
• 11.23 AbbVie
  • 11.23.1 AbbVie Company Details
  • 11.23.2 AbbVie Business Overview
  • 11.23.3 AbbVie Pharmaceutical CXO Introduction
  • 11.23.4 AbbVie Revenue in Pharmaceutical CXO Business (2018-2023)
  • 11.23.5 AbbVie Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer
• 13.3 Author Details

List of Tables

• Table 1. Global Pharmaceutical CXO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
• Table 2. Key Players of CRO
• Table 3. Key Players of CMO
• Table 4. Key Players of CDMO
• Table 5. Global Pharmaceutical CXO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
• Table 6. Global Pharmaceutical CXO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 7. Global Pharmaceutical CXO Market Size by Region (2018-2023) & (US$ Million)
• Table 8. Global Pharmaceutical CXO Market Share by Region (2018-2023)
• Table 9. Global Pharmaceutical CXO Forecasted Market Size by Region (2024-2029) & (US$ Million)
• Table 10. Global Pharmaceutical CXO Market Share by Region (2024-2029)
• Table 11. Pharmaceutical CXO Market Trends
• Table 12. Pharmaceutical CXO Market Drivers
• Table 13. Pharmaceutical CXO Market Challenges
• Table 14. Pharmaceutical CXO Market Restraints
• Table 15. Global Pharmaceutical CXO Revenue by Players (2018-2023) & (US$ Million)
• Table 16. Global Pharmaceutical CXO Revenue Share by Players (2018-2023)
• Table 17. Global Top Pharmaceutical CXO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2022)
• Table 18. Global Pharmaceutical CXO Industry Ranking 2021 VS 2022 VS 2023
• Table 19. Global 5 Largest Players Market Share by Pharmaceutical CXO Revenue (CR5 and HHI) & (2018-2023)
• Table 20. Global Key Players of Pharmaceutical CXO, Headquarters and Area Served
• Table 21. Global Key Players of Pharmaceutical CXO, Product and Application
• Table 22. Global Key Players of Pharmaceutical CXO, Product and Application
• Table 23. Mergers & Acquisitions, Expansion Plans
• Table 24. Global Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
• Table 25. Global Pharmaceutical CXO Revenue Market Share by Type (2018-2023)
• Table 26. Global Pharmaceutical CXO Forecasted Market Size by Type (2024-2029) & (US$ Million)
• Table 27. Global Pharmaceutical CXO Revenue Market Share by Type (2024-2029)
• Table 28. Global Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
• Table 29. Global Pharmaceutical CXO Revenue Share by Application (2018-2023)
• Table 30. Global Pharmaceutical CXO Forecasted Market Size by Application (2024-2029) & (US$ Million)
• Table 31. Global Pharmaceutical CXO Revenue Share by Application (2024-2029)
• Table 32. North America Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
• Table 33. North America Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
• Table 34. North America Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
• Table 35. North America Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
• Table 36. North America Pharmaceutical CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 37. North America Pharmaceutical CXO Market Size by Country (2018-2023) & (US$ Million)
• Table 38. North America Pharmaceutical CXO Market Size by Country (2024-2029) & (US$ Million)
• Table 39. Europe Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
• Table 40. Europe Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
• Table 41. Europe Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
• Table 42. Europe Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
• Table 43. Europe Pharmaceutical CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 44. Europe Pharmaceutical CXO Market Size by Country (2018-2023) & (US$ Million)
• Table 45. Europe Pharmaceutical CXO Market Size by Country (2024-2029) & (US$ Million)
• Table 46. China Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
• Table 47. China Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
• Table 48. China Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
• Table 49. China Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
• Table 50. Asia Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
• Table 51. Asia Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
• Table 52. Asia Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
• Table 53. Asia Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
• Table 54. Asia Pharmaceutical CXO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 55. Asia Pharmaceutical CXO Market Size by Region (2018-2023) & (US$ Million)
• Table 56. Asia Pharmaceutical CXO Market Size by Region (2024-2029) & (US$ Million)
• Table 57. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
• Table 58. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
• Table 59. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
• Table 60. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
• Table 61. Middle East, Africa, and Latin America Pharmaceutical CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 62. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2018-2023) & (US$ Million)
• Table 63. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2024-2029) & (US$ Million)
• Table 64. WuXi AppTec Company Details
• Table 65. WuXi AppTec Business Overview
• Table 66. WuXi AppTec Pharmaceutical CXO Product
• Table 67. WuXi AppTec Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 68. WuXi AppTec Recent Developments
• Table 69. Tigermed Company Details
• Table 70. Tigermed Business Overview
• Table 71. Tigermed Pharmaceutical CXO Product
• Table 72. Tigermed Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 73. Tigermed Recent Developments
• Table 74. Charles River Laboratories Company Details
• Table 75. Charles River Laboratories Business Overview
• Table 76. Charles River Laboratories Pharmaceutical CXO Product
• Table 77. Charles River Laboratories Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 78. Charles River Laboratories Recent Developments
• Table 79. Pharmaron Inc Company Details
• Table 80. Pharmaron Inc Business Overview
• Table 81. Pharmaron Inc Pharmaceutical CXO Product
• Table 82. Pharmaron Inc Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 83. Pharmaron Inc Recent Developments
• Table 84. Labcorp Drug Development Company Details
• Table 85. Labcorp Drug Development Business Overview
• Table 86. Labcorp Drug Development Pharmaceutical CXO Product
• Table 87. Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 88. Labcorp Drug Development Recent Developments
• Table 89. Boehringer Ingelheim Company Details
• Table 90. Boehringer Ingelheim Business Overview
• Table 91. Boehringer Ingelheim Pharmaceutical CXO Product
• Table 92. Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 93. Boehringer Ingelheim Recent Developments
• Table 94. GenScript Company Details
• Table 95. GenScript Business Overview
• Table 96. GenScript Pharmaceutical CXO Product
• Table 97. GenScript Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 98. GenScript Recent Developments
• Table 99. MabPlex International Company Details
• Table 100. MabPlex International Business Overview
• Table 101. MabPlex International Pharmaceutical CXO Product
• Table 102. MabPlex International Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 103. MabPlex International Recent Developments
• Table 104. Shanghai ChemPartner Company Details
• Table 105. Shanghai ChemPartner Business Overview
• Table 106. Shanghai ChemPartner Pharmaceutical CXO Product
• Table 107. Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 108. Shanghai ChemPartner Recent Developments
• Table 109. Wuxi Biologics Company Details
• Table 110. Wuxi Biologics Business Overview
• Table 111. Wuxi Biologics Pharmaceutical CXO Product
• Table 112. Wuxi Biologics Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 113. Wuxi Biologics Recent Developments
• Table 114. Pharmablock Company Details
• Table 115. Pharmablock Business Overview
• Table 116. Pharmablock Pharmaceutical CXO Product
• Table 117. Pharmablock Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 118. Pharmablock Recent Developments
• Table 119. Jiuzhou Pharma Company Details
• Table 120. Jiuzhou Pharma Business Overview
• Table 121. Jiuzhou Pharma Pharmaceutical CXO Product
• Table 122. Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 123. Jiuzhou Pharma Recent Developments
• Table 124. Asym Chemical Company Details
• Table 125. Asym Chemical Business Overview
• Table 126. Asym Chemical Pharmaceutical CXO Product
• Table 127. Asym Chemical Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 128. Asym Chemical Recent Developments
• Table 129. IQVIA Company Details
• Table 130. IQVIA Business Overview
• Table 131. IQVIA Pharmaceutical CXO Product
• Table 132. IQVIA Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 133. IQVIA Recent Developments
• Table 134. Syneos Health Company Details
• Table 135. Syneos Health Business Overview
• Table 136. Syneos Health Pharmaceutical CXO Product
• Table 137. Syneos Health Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 138. Syneos Health Recent Developments
• Table 139. Parexel Company Details
• Table 140. Parexel Business Overview
• Table 141. Parexel Pharmaceutical CXO Product
• Table 142. Parexel Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 143. Parexel Recent Developments
• Table 144. AGC Biologics Company Details
• Table 145. AGC Biologics Business Overview
• Table 146. AGC Biologics Pharmaceutical CXO Product
• Table 147. AGC Biologics Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 148. AGC Biologics Recent Developments
• Table 149. FUJIFILM Diosynth Biotechnologies Company Details
• Table 150. FUJIFILM Diosynth Biotechnologies Business Overview
• Table 151. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product
• Table 152. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 153. FUJIFILM Diosynth Biotechnologies Recent Developments
• Table 154. Patheon Company Details
• Table 155. Patheon Business Overview
• Table 156. Patheon Pharmaceutical CXO Product
• Table 157. Patheon Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 158. Patheon Recent Developments
• Table 159. Catalent Company Details
• Table 160. Catalent Business Overview
• Table 161. Catalent Pharmaceutical CXO Product
• Table 162. Catalent Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 163. Catalent Recent Developments
• Table 164. Lonza Group AG Company Details
• Table 165. Lonza Group AG Business Overview
• Table 166. Lonza Group AG Pharmaceutical CXO Product
• Table 167. Lonza Group AG Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 168. Lonza Group AG Recent Developments
• Table 169. Avid Bioservices Company Details
• Table 170. Avid Bioservices Business Overview
• Table 171. Avid Bioservices Pharmaceutical CXO Product
• Table 172. Avid Bioservices Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 173. Avid Bioservices Recent Developments
• Table 174. AbbVie Company Details
• Table 175. AbbVie Business Overview
• Table 176. AbbVie Pharmaceutical CXO Product
• Table 177. AbbVie Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
• Table 178. AbbVie Recent Developments
• Table 179. Research Programs/Design for This Report
• Table 180. Key Data Information from Secondary Sources
• Table 181. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Pharmaceutical CXO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 2. Global Pharmaceutical CXO Market Share by Type: 2022 VS 2029
• Figure 3. CRO Features
• Figure 4. CMO Features
• Figure 5. CDMO Features
• Figure 6. Global Pharmaceutical CXO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global Pharmaceutical CXO Market Share by Application: 2022 VS 2029
• Figure 8. Pharmaceutical Companies Case Studies
• Figure 9. Biotechnology Companies Case Studies
• Figure 10. Pharmaceutical CXO Report Years Considered
• Figure 11. Global Pharmaceutical CXO Market Size (US$ Million), Year-over-Year: 2018-2029
• Figure 12. Global Pharmaceutical CXO Market Size, (US$ Million), 2018 VS 2022 VS 2029
• Figure 13. Global Pharmaceutical CXO Market Share by Region: 2022 VS 2029
• Figure 14. Global Pharmaceutical CXO Market Share by Players in 2022
• Figure 15. Global Top Pharmaceutical CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2022)
• Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical CXO Revenue in 2022
• Figure 17. North America Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 18. North America Pharmaceutical CXO Market Share by Type (2018-2029)
• Figure 19. North America Pharmaceutical CXO Market Share by Application (2018-2029)
• Figure 20. North America Pharmaceutical CXO Market Share by Country (2018-2029)
• Figure 21. United States Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 22. Canada Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 23. Europe Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
• Figure 24. Europe Pharmaceutical CXO Market Share by Type (2018-2029)
• Figure 25. Europe Pharmaceutical CXO Market Share by Application (2018-2029)
• Figure 26. Europe Pharmaceutical CXO Market Share by Country (2018-2029)
• Figure 27. Germany Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 28. France Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 29. U.K. Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 30. Italy Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 31. Russia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 32. Nordic Countries Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 33. China Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
• Figure 34. China Pharmaceutical CXO Market Share by Type (2018-2029)
• Figure 35. China Pharmaceutical CXO Market Share by Application (2018-2029)
• Figure 36. Asia Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
• Figure 37. Asia Pharmaceutical CXO Market Share by Type (2018-2029)
• Figure 38. Asia Pharmaceutical CXO Market Share by Application (2018-2029)
• Figure 39. Asia Pharmaceutical CXO Market Share by Region (2018-2029)
• Figure 40. Japan Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 41. South Korea Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 42. China Taiwan Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 43. Southeast Asia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 44. India Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 45. Australia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 46. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
• Figure 47. Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Type (2018-2029)
• Figure 48. Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Application (2018-2029)
• Figure 49. Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Country (2018-2029)
• Figure 50. Brazil Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 51. Mexico Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 52. Turkey Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 53. Saudi Arabia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 54. Israel Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 55. GCC Countries Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 56. WuXi AppTec Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 57. Tigermed Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 58. Charles River Laboratories Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 59. Pharmaron Inc Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 60. Labcorp Drug Development Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 61. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 62. GenScript Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 63. MabPlex International Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 64. Shanghai ChemPartner Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 65. Wuxi Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 66. Pharmablock Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 67. Jiuzhou Pharma Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 68. Asym Chemical Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 69. IQVIA Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 70. Syneos Health Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 71. Parexel Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 72. AGC Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 73. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 74. Patheon Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 75. Catalent Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 76. Lonza Group AG Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 77. Avid Bioservices Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 78. AbbVie Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
• Figure 79. Bottom-up and Top-down Approaches for This Report
• Figure 80. Data Triangulation
• Figure 81. Key Executives Interviewed